Sign Out
Hypersensitivity: As with all beta-lactam antibacterial agents, serious and occasionally fatal hypersensitivity reactions have been reported. In case of severe hypersensitivity reactions, treatment with Ceftazidime must be discontinued immediately and adequate emergency measures must be initiated.
Pseudomembranous colitis: Antibacterial agent-associated colitis and pseudomembranous colitis have been reported with nearly all antibacterial agents, including Ceftazidime, and may range in severity from mild to life-threatening.
Renal function: Concurrent treatment with high doses of cephalosporins and nephrotoxic medicinal products such as aminoglycosides or potent diuretics (e.g., furosemide) may adversely affect renal function.
Overgrowth of non-susceptible organisms: Prolonged use may result in the overgrowth of non-susceptible organisms (e.g., Enterococci, fungi) which may require interruption of treatment or other appropriate measures. Repeated evaluation of the patient's condition is essential.
Continue with Google